Case review finds intravenous dexamethasone effectively resolves serous retinal detachment after laser therapy for ROP, suggesting a promising treatment option.
Purpose: To describe the clinical course and management of serous retinal detachment following laser ablative therapy for retinopathy of prematurity (ROP). Methods: Two cases (4 eyes) were reviewed. Results: Four eyes from 2 patients who developed serous retinal detachments after undergoing laser ablative therapy for type 1 pre-threshold ROP were included. Both patients were treated with 0.6 mg/kg of intravenous dexamethasone every 6 hours, following a regimen commonly used in the management of bronchopulmonary dysplasia. All eyes demonstrated rapid resolution of serous retinal detachment following initiation of systemic corticosteroid therapy. No immediate treatment-related complications were observed. Conclusions: Intravenous dexamethasone may be a safe and effective treatment for serous retinal detachment after laser therapy for ROP. Further studies are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Kirk et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: